Reproducibility of creatine kinase reaction kinetics in human heart: A 31P time-dependent saturation transfer spectroscopy study

NMR in Biomedicine

Volumn 27, Issue 6, 2014, Pages 663-671

  Bashir, Adil ^a   Gropler, Robert ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine triphosphate (ATP); Creatine kinase; Heart; Image selected in vivo spectroscopy (ISIS); Reproducibility; Saturation transfer; Time dependent saturation transfer (TDST)

Indexed keywords

ADENOSINETRIPHOSPHATE; ASSOCIATION REACTIONS; ENZYMES; METABOLISM; PHOSPHATES; RATE CONSTANTS; REACTION KINETICS; TISSUE REGENERATION;

CREATINE KINASE; IN-VIVO SPECTROSCOPY; REPRODUCIBILITIES; SATURATION TRANSFER;

HEART;

CREATINE KINASE; CREATINE PHOSPHATE; PHOSPHORUS;

ADULT; ARTICLE; CHEMICAL REACTION KINETICS; CLINICAL PROTOCOL; CORRELATION COEFFICIENT; ENERGY METABOLISM; FEMALE; HEART MUSCLE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; METABOLIC PARAMETERS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOFREQUENCY; RADIOLOGICAL PARAMETERS; RELIABILITY; REPRODUCIBILITY; SAMPLE SIZE; TEST RETEST RELIABILITY; TIME DEPENDENT SATURATION TRANSFER; DIAGNOSTIC USE; ENZYMOLOGY; KINETICS; METABOLISM; MIDDLE AGED; MONTE CARLO METHOD; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

ADULT; CREATINE KINASE; FEMALE; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MONTE CARLO METHOD; MYOCARDIUM; PHOSPHORUS ISOTOPES; REPRODUCIBILITY OF RESULTS;

EID: 84899931981     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3103     Document Type: Article

References (43)

1. Lipskaya TY. Mitochondrial creatine kinase: properties and function. Biochemistry (Moscow) 2001; 66(10): 1098-1111.
2. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996; 94(8): 1894-1901.
3. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R. Subcellular creatine kinase alterations. Implications in heart failure. Circ. Res. 1999; 85(1): 68-76.
4. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 1995; 91(6): 1824-1833.
5. Tian R, Nascimben L, Kaddurah-Daouk R, Ingwall JS. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J. Mol. Cell. Cardiol. 1996; 28(4): 755-765.
6. Field ML, Clark JF, Henderson C, Seymour AM, Radda GK. Alterations in the myocardial creatine kinase system during chronic anaemic hypoxia. Cardiovasc. Res. 1994; 28(1): 86-91.
7. Sharkey SW, Murakami MM, Smith SA, Apple FS. Canine myocardial creatine kinase isoenzymes after chronic coronary artery occlusion. Circulation 1991; 84(1): 333-340.
8. Smith SH, Kramer MF, Reis I, Bishop SP, Ingwall JS. Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. Circ. Res. 1990; 67(6): 1334-1344.
9. 31P NMR magnetization transfer study. J. Biol. Chem. 1985; 260(6): 3512-3517.
10. 31P magnetization transfer study. Magn. Reson. Med. 1997; 38(4): 551-557.
11. Sauter A, Rudin M. Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function. J. Biol. Chem. 1993; 268(18): 13 166-13 171.
12. Forsén S, Hoffman RA. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J. Chem. Phys. 1964; 39: 2892-2901.
13. 31P-NMR surface coil studies in living rat. Circ. Res. 1987; 60(6): 871-878.
14. Hamman BL, Bittl JA, Jacobus WE, Allen PD, Spencer RS, Tian R, Ingwall JS. Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. Am. J. Physiol. 1995; 269(3 Pt 2): H1030-H1036.
15. Matsumoto Y, Kaneko M, Kobayashi A, Fujise Y, Yamazaki N. Creatine kinase kinetics in diabetic cardiomyopathy. Am. J. Physiol. 1995; 268(6 Pt 1): E1070-E1076.
16. Xiong Q, Li Q, Mansoor A, Jameel MN, Du F, Chen W, Zhang J. Novel strategy for measuring creatine kinase reaction rate in the in vivo heart. Am. J. Physiol. Heart Circ. Physiol. 2009; 297(3): H1010-H1019.
17. Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG. Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn. Reson. Med. 2002; 47(5): 850-863.
18. Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation 2006; 114(11): 1151-1158.
19. 31P spectroscopy for measuring human creatine kinase reaction kinetics. Magn. Reson. Med. 2010; 63(6): 1493-1501.
20. Bashir A, Yablonskiy DA. Natural linewidth chemical shift imaging (NL-CSI). Magn. Reson. Med. 2006; 56(1): 7-18.
21. Alger JR, Shulman RG. NMR studies of enzymatic rates in vitro and in vivo by magnetization transfer. Q. Rev. Biophys. 1984; 17(1): 83-124.
22. Brindle KM. NMR methods for measuring enzyme kinetics in vivo. Prog. Nucl. Magn. Reson. Spectrosc. 1988; 20(3): 257-293.
23. Kuchel PW. Spin-exchange NMR spectroscopy in studies of the kinetics of enzymes and membrane transport. NMR Biomed. 1990; 3(3): 102-119.
24. 31P spectroscopy at 3 Tesla using adiabatic pulses. Magn. Reson. Med. 2009; 61(4): 785-795.
25. Weglage J, Wiedermann D, Denecke J, Feldmann R, Koch HG, Ullrich K, Harms E, Moller HE. Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann. Neurol. 2001; 50(4): 463-467.
26. 31P NMR spectroscopy of the human heart at 4 T: detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium. Magn. Reson. Med. 1992; 26(2): 368-376.
27. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001; 12: 141-152.
28. Vanhamme L, Van Huffel S, Van Hecke P, van Ormondt D. Time-domain quantification of series of biomedical magnetic resonance spectroscopy signals. J. Magn. Reson. 1999; 140(1): 120-130.
29. Wiedermann D, Schneider J, Fromme A, Thorwesten L, Moller HE. Creatine loading and resting skeletal muscle phosphocreatine flux: a saturation-transfer NMR study. MAGMA 2001; 13(2): 118-126.
30. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992; 86(6): 1810-1818.
31. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1(8476): 307-310.
32. 31P NMR saturation transfer study of the creatine kinase reaction in human skeletal muscle at rest and during exercise. Magn. Reson. Med. 1997; 37(5): 744-753.
33. Tyler DJ, Hudsmith LE, Clarke K, Neubauer S, Robson MD. A comparison of cardiac (31)P MRS at 1.5 and 3 T. NMR Biomed. 2008; 21(8): 793-798. DOI: 10.1002/mrm.24922
34. Rodgers CT, Clarke WT, Snyder C, Vaughan JT, Neubauer S, Robson MD. Human cardiac P magnetic resonance spectroscopy at 7 tesla. Magn. Reson. Med. 2013.
35. Koretsky AP, Basus VJ, James TL, Klein MP, Weiner MW. Detection of exchange reactions involving small metabolite pools using NMR magnetization transfer techniques: relevance to subcellular compartmentation of creatine kinase. Magn. Reson. Med. 1985; 2(6): 586-594.
36. 31P NMR saturation transfer measurements of the steady state rates of creatine kinase and ATP synthetase in the rat brain. FEBS Lett. 1982; 140(2): 289-292.
37. Du F, Zhang Y, Chen W. Relayed magnetization transfer from nuclear Overhauser effect and chemical exchange observed by in vivo (3)(1)P MRS in rat brain. Magn. Reson. Imaging 2012; 30(5): 716-721.
38. Hudsmith LE, Neubauer S. Detection of myocardial disorders by magnetic resonance spectroscopy. Nat. Clin. Pract. Cardiovasc. Med. 2008; 5(Suppl 2): S49-S56.
39. Hudsmith LE, Neubauer S. Magnetic resonance spectroscopy in myocardial disease. JACC Cardiovasc. Imaging, 2009; 2(1): 87-96.
40. 31P-MRS study. J. Appl. Physiol.. 1999; 87(1): 116-123.
41. 31P magnetic resonance spectroscopy. Lancet, 1991; 338(8773): 973-976.
42. 31P MR spectroscopy. Magn. Reson. Med. 2006; 56(4): 907-911.
43. Lamb HJ, Beyerbacht HP, van der Laarse A, Stoel BC, Doornbos J, van der Wall EE, de Roos A. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation, 1999; 99(17): 2261-2267.